Good evening :)
CCME Global Ltd

CCME Global Ltd

CCME Share Price

BSE
31.505.00% (+1.50)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹39 cr, stock is ranked 4,066

Stock is 4.81x as volatile as Nifty

CCME Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹39 cr, stock is ranked 4,066

Stock is 4.81x as volatile as Nifty

CCME Performance & Key Metrics

CCME Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-45.880.97
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
46.995.890.48%

CCME Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

CCME Company Profile

Genesis IBRC India Ltd is a biotechnology company focused on developing and marketing microbial and antimicrobial products for aquaculture, agriculture, poultry, and animal husbandry sectors.

CCME Similar Stocks (Peers)

Compare with peers Compare with peers 

CCME Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
165.02
165.02
1Y Return
6.43%
6.43%
Buy Reco %
64.29
64.29
PE Ratio
89.55
89.55
1Y Return
12.87%
12.87%
Buy Reco %
100.00
100.00
PE Ratio
96.49
96.49
1Y Return
75.17%
75.17%
Buy Reco %
85.71
85.71
PE Ratio
77.76
77.76
1Y Return
123.71%
123.71%
Buy Reco %
88.89
88.89
PE Ratio
-247.37
-247.37
1Y Return
12.45%
12.45%
Buy Reco %
100.00
100.00
Compare with Peers

CCME Forecast

CCME Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

CCME

CCME

Income

Balance Sheet

Cash Flow

CCME Income Statement

CCME Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue0.000.003.670.000.000.000.000.000.040.00
Operating & Other expensessubtract3.690.100.020.030.020.120.060.030.540.24
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.000.02
Interest & Other Itemssubtract0.000.000.000.000.000.000.000.000.000.00
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.000.00
EPS-2.84-0.072.81-0.02-0.02-0.09-0.05-0.02-0.37-0.06

CCME Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

CCME Stock Peers

CCME Past Performance & Peer Comparison

CCME Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
CCME Global Ltd-54.930.97
Biocon Limited165.021.740.13%
Anthem Biosciences Limited89.5517.420.21%
Sai Life Sciences Limited96.4913.55

CCME Stock Price Comparison

Compare CCME with any stock or ETF
Compare CCME with any stock or ETF
CCME
Loading...

CCME Holdings

CCME Shareholdings

CCME Promoter Holdings Trend

CCME Promoter Holdings Trend

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 63.02%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

CCME Institutional Holdings Trend

CCME Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 2.60%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

CCME Shareholding Pattern

CCME Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding74.35%0.00%0.00%0.00%25.65%

Dec 2025

Mar 2026

Apr 2026

Jun 2026

CCME Shareholding History

CCME Shareholding History

JunSepDec '25MarAprJun0.00%0.00%0.00%0.00%0.00%0.00%

CCME Insider Trades & Bulk Stock Deals

CCME Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing CCME stock

smallcases containing CCME stock

Looks like this stock is not in any smallcase yet.

CCME Events

CCME Events

CCME Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

CCME has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

CCME Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

CCME has not given any dividends in last 5 years

CCME Dividends

CCME Dividends

Hmm, looks like data is unavailable here. Please come back after some time

CCME Stock News & Opinions

CCME Stock News & Opinions

Corporate
Corporate
CCME Global closes member register ahead of its 34th Annual General Meeting

CCME Global Limited, formerly known as Genesis IBRC India Limited, will close its Register of Members and Share Transfer Books from Wednesday, September 23, 2026, to Tuesday, September 29, 2026, for its 34th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 3:00 p.m. (IST).

1 week agoCapital Market - Live
Spotlight
Spotlight
CCME Global issues shares to acquire subsidiaries, valuing Interlink and CCME UAE

CCME Global Limited, formerly Genesis IBRC India Limited, is undertaking a series of corporate actions including acquisitions and a stock split, as detailed in a regulatory filing as of August 29, 2026. The company plans to acquire 100% of CCME UAE and 52% of Interlink, issuing a total of 19,63,17,249 shares with a face value of INR 10 each for these acquisitions, based on valuations from an Independent Registered Valuer and a Category I Merchant Banker. Additionally, CCME Global Limited intends to execute a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, aiming to enhance liquidity and broaden accessibility for smaller investors, with completion expected during fiscal year 2026-2027. The company’s authorized, issued, and paid-up share capital will be impacted by the split, but no shareholders were left without shares. Managing Director Poonam Chaturvedi oversees these changes.

2 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global completes acquisition of Interlink Distribution LLC, plans stock split

CCME Global Limited, formerly Genesis IBRC India Limited, has undertaken significant corporate actions including preferential allotments of shares to facilitate the acquisition of Interlink Distribution LLC and related entities, with shareholders such as Mr. Mostafa Ahmed Kabir and Mr. Poonam Chaturvedi participating. The company is also planning a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, intended to enhance liquidity and broaden accessibility for smaller investors, with completion anticipated within the fiscal year 2026-2027. These moves, approved by the Board of Directors and compliant with SEBI regulations, reflect a period of substantial growth for the company, as demonstrated by the considerable number of shares issued and a consistent paid-up capital of INR 196,31,72,490 both before and after the planned split.

2 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global completed share allotments to acquire CCME UAE and Interlink Distribution LLC

CCME Global Limited, formerly Genesis IBRC India Limited, has completed a preferential allotment of shares to facilitate the acquisitions of CCME UAE and Interlink Distribution LLC, and approved a 1:10 stock split intended to enhance liquidity and broaden investor accessibility. The company allotted 19,63,17,249 shares to Mr. Mostafa Ahmed Kabir, who holds a 52% stake in Interlink Distribution LLC, receiving 2,03,42,249 shares in exchange. The stock split will reduce the face value of equity shares from INR 10 to INR 1 and is expected to be completed during the current fiscal year. Managing Director Poonam Chaturvedi oversaw the transactions, which were valued by an Independent Registered Valuer and a Category I Merchant Banker, and represent a filing required for regulatory compliance.

2 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global Limited plans a 1:10 stock split to broaden investor accessibility

CCME Global Limited, formerly Genesis IBRC India Limited, announced preferential allotments of shares to acquire 52% stakes in CCME UAE and Interlink, alongside acquisitions of other entities involving Managing Director Poonam Chaturvedi and others. The company’s authorized share capital is INR 200 crore, with an issued and subscribed share capital of INR 196.32 crore and a paid-up share capital of the same amount, comprising 19.63 crore shares with a face value of INR 10 each. To enhance liquidity and broaden investor accessibility, CCME Global Limited plans a 1:10 stock split within the current fiscal year, which will increase the number of equity shares to 196.32 crore with a face value of INR 1 per share. The acquisitions and stock split are being formally disclosed in compliance with Securities and Exchange Board of India (SEBI) regulations.

2 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global acquires 52% stake in Interlink Distribution LLC for INR 196.32 crore

CCME Global Limited, formerly Genesis IBRC India Limited, is undertaking several capital structure changes, including acquisitions and a stock split expected to be completed in the current fiscal year 2026-2027. The company has allotted shares to acquire 52% of Interlink Distribution LLC and a corresponding stake held by Mostafa Ahmed Kabir, for a total value of INR 196,31,72,490. Separately, CCME Global Limited plans a 1:10 stock split, reducing the face value per share from INR 10 to INR 1 to enhance liquidity and broaden investor participation. Following the split, the authorized, issued, subscribed, and paid-up share capital will remain at 20,00,00,000 shares with a total value of INR 200,00,00,000. Poonam Chaturvedi serves as Managing Director of CCME Global Limited.

2 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global to consider fundraising, share sub-division, and other corporate actions

CCME Global Limited, formerly known as Genesis IBRC India Limited, will hold a board meeting on August 29, 2026, to consider matters including an increase in the company’s authorized share capital and alteration of its memorandum of association, evaluating a potential fundraising through equity shares or other eligible securities, sub-division of share capital, approval of the Directors Report for the financial year ended March 31, 2026, acquisition of entities, a shift in the registered office, and the convening of the Annual General Meeting.

3 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global Limited announces the passing of Independent Director Ashok Chhaganbhai Patel

CCME Global Limited, formerly known as Genesis IBRC India Limited, informed the Bombay Stock Exchange on August 18, 2026, of the death of Independent Non-Executive Director Ashok Chhaganbhai Patel, whose death occurred on August 15, 2026.

4 weeks agoCapital Market - Live
Corporate
Corporate
CCME Global’s board approved Q1 2026 results and appointed internal auditors

CCME Global Limited, formerly known as Genesis IBRC India Limited, announced that its board approved the unaudited financial results for the first quarter ending June 30, 2026, along with a limited review report, and appointed M/s G J M S & Associates LLP as internal auditors for the fiscal year 2026-2027. The company also reported that there was no deviation in the utilization of Rs 32.25 crore raised through a preferential issue in March 2026, which was allocated to expanding its FMCG and commodities business, working capital for its import & export business, strategic investments, and general corporate purposes.

1 month agoCapital Market - Live
Corporate
Corporate
CCME Global to review Q1 financial results at a board meeting on August 14

CCME Global Limited, formerly known as Genesis IBRC India Limited, will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results along with the limited review report for the first quarter ending June 30, 2026, according to a regulatory filing. The company’s trading window for securities will remain closed until 48 hours after the declaration of the unaudited standalone financial results.

1 month agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of CCME as on 15th September 2026 is ₹31.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of CCME Global Ltd (CCME) share are
    • Past 1 week: 13.23%
    • Past 1 month: -49.76%
    • Past 3 months: -67.84%
    • Past 6 months: -68.18%
    • Past 1 year: -38.17%
    • Past 3 years: 180.25%
    • Past 5 years: 303.33%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of CCME Global Ltd (CCME) is ₹39 Cr as of 15th September 2026.

  4. The 52-week high of CCME Global Ltd (CCME) is ₹184.90 and the 52-week low is ₹26.41.

  5. The P/E (price-to-earnings) ratio of CCME Global Ltd (CCME) is -54.93. The P/B (price-to-book) ratio is 0.97.

  6. CCME Global Ltd (CCME) belongs to the Health Care sector & Biotechnology sub-sector.

  7. You can directly buy CCME Global Ltd (CCME) shares on Tickertape. Simply sign up, connect your demat account and place your order.